Puma Biotechnology (PBYI) EPS (Basic) Growth (1y) (2012 - 2026)
Powered by 
Analysis
Puma Biotechnology (PBYI) EPS (Basic) Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 7.74% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -4.72% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 87.85% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7.59% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 143.95% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 322.67% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -16.29% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 96.41% |
| 10 | Puma Biotechnology | 486.99 Mn | 393.08 Mn | 44.03 Mn | 36.46% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.46% |
| Mar 31, 2026 | -223.09% |
| Dec 31, 2025 | 32.69% |
| Sep 30, 2025 | -57.62% |
| Jun 30, 2025 | 225.62% |
| Mar 31, 2025 | 160.01% |
| Dec 31, 2024 | -3.41% |
| Sep 30, 2024 | 239.89% |
| Jun 30, 2024 | -306.27% |
| Mar 31, 2024 | -432.61% |
| Dec 31, 2023 | 307.42% |
| Sep 30, 2023 | 1,643.85% |
| Jun 30, 2023 | -78.14% |
| Mar 31, 2023 | 137.26% |
| Dec 31, 2022 | 71.89% |
| Sep 30, 2022 | 99.28% |
| Jun 30, 2022 | 264.88% |
| Mar 31, 2022 | -119.64% |
| Dec 31, 2021 | -17.82% |
| Sep 30, 2021 | -38.09% |